Top Stories
Designed to operate with minimal user interaction, MIM Contour ProtégéAI+ 2.0 automatically initiates contouring.
The results come a week after Noom rolled out its at-home test kit evaluating 17 biomarkers across cardiovascular, metabolic, hormonal, inflammatory and nutritional health.
The update adds compatibility with Abbott’s FreeStyle Libre 3 Plus sensor to Omnipod 5 and introduces a 100 mg/dL glucose target for automated insulin delivery.
The deal gives ResMed a non-drug wearable therapy for restless legs syndrome, moving it further into sleep care beyond its core CPAP business.
The startup has also launched a patient-facing mobile app that allows users to access their complete health history.
Conference News
ALBUQUERQUE, NM, UNITED STATES, June 4, 2026 /EINPresswire.com/ -- T-NeuroDx, a biotechnology company developing novel immune-based diagnostics for early detection of Alzheimer’s disease, announced to...
Rapid diagnostic clarity enables targeted treatment while avoiding neurosurgery benefiting patientsBOSTON--(BUSINESS WIRE)-- Delve Bio, a UCSF spin-out and pioneer in metagenomic next-generation seque...
Presentations will feature next generation Omnipod innovations designed to reduce user effort, new algorithm data, and clinical evidence demonstrating improved time in rangeInsulet-led sessions will h...
WASHINGTON--(BUSINESS WIRE)-- At ASM Microbe 2026, Bruker Corporation’s (Nasdaq: BRKR) Microbiology & Infection Diagnostics (BMID) division is demonstrating its expanding portfolio and innovations acr...
Highly anticipated presentation of results from the CONNECT randomized control trial will be presented during the ADA Scientific Sessions conference on Saturday, June 6 at 1:45 p.m. CDT.Early access l...
